Renaissance Technologies’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-611,300
| Closed | -$972K | – | 4107 |
|
|
2024
Q1 | $972K | Sell |
611,300
-145,592
| -19% | -$231K | ﹤0.01% | 2507 |
|
|
2023
Q4 | $650K | Buy |
756,892
+234,565
| +45% | +$201K | ﹤0.01% | 2655 |
|
|
2023
Q3 | $559K | Buy |
522,327
+269,727
| +107% | +$289K | ﹤0.01% | 2659 |
|
|
2023
Q2 | $654K | Sell |
252,600
-76,900
| -23% | -$199K | ﹤0.01% | 2730 |
|
|
2023
Q1 | $1.34M | Sell |
329,500
-14,000
| -4% | -$57.1K | ﹤0.01% | 2271 |
|
|
2022
Q4 | $1.72M | Buy |
343,500
+69,300
| +25% | +$348K | ﹤0.01% | 2166 |
|
|
2022
Q3 | $3.59M | Sell |
274,200
-64,168
| -19% | -$839K | 0.01% | 1645 |
|
|
2022
Q2 | $4.34M | Buy |
338,368
+182,668
| +117% | +$2.34M | 0.01% | 1669 |
|
|
2022
Q1 | $2.37M | Buy |
155,700
+81,000
| +108% | +$1.24M | ﹤0.01% | 2110 |
|
|
2021
Q4 | $1.32M | Buy |
74,700
+61,400
| +462% | +$1.09M | ﹤0.01% | 2454 |
|
|
2021
Q3 | $280K | Buy |
+13,300
| New | +$280K | ﹤0.01% | 3103 |
|
|
2020
Q4 | – | Sell |
-82,200
| Closed | -$1.31M | – | 3799 |
|
|
2020
Q3 | $1.31M | Sell |
82,200
-86,800
| -51% | -$1.38M | ﹤0.01% | 2367 |
|
|
2020
Q2 | $3.34M | Buy |
169,000
+19,900
| +13% | +$393K | ﹤0.01% | 1873 |
|
|
2020
Q1 | $1.84M | Buy |
+149,100
| New | +$1.84M | ﹤0.01% | 2093 |
|